Valuation: IDEXX Laboratories, Inc.

Market Cap 4.38TCr 22TCr 3.9TCr 3.61TCr 3.27TCr 6.15TCr 4,14800Cr 6.25TCr 43TCr 17TCr 2,17100Cr 16TCr 16TCr 6,92500Cr P/E 2026 *
37.6x
P/E 2027 * 33.4x
Enterprise Value 4.42TCr 22TCr 3.93TCr 3.64TCr 3.3TCr 6.2TCr 4,18300Cr 6.31TCr 44TCr 17TCr 2,18900Cr 17TCr 16TCr 6,98300Cr EV / Sales 2026 *
9.35x
EV / Sales 2027 * 8.49x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+2.81%
1 week+5.82%
Current month+1.55%
1 month+3.49%
3 months-0.26%
6 months-6.14%
Current year-27.66%
1 week 531.51
Extreme 531.51
546.43
1 month 509.99
Extreme 509.99
546.43
Current year 509.99
Extreme 509.99
773.97
1 year 509.99
Extreme 509.99
813.6
3 years 439
Extreme 439
813.6
5 years 336.6
Extreme 336.6
813.6
10 years 225.06
Extreme 225.055
813.6
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+2.81%+5.82% - - 4.38TCr
-1.48%-0.49%-21.16%+5.51% 18TCr
+1.87%+1.91%-1.18%+30.39% 11TCr
+2.27%+7.77%-20.13%+14.61% 11TCr
-1.02%+2.87%-52.05%-7.70% 7.84TCr
+0.80%+3.76%+4.62%+81.47% 6.49TCr
+1.60%+3.73%+17.39%+76.86% 5.4TCr
+1.32%+3.34%+1.37%-25.14% 5.2TCr
+0.07%+6.97%-13.49%+30.35% 4.38TCr
-0.26%+0.81%+25.30%-0.26% 3.24TCr
Average +0.80%+2.96%-6.59%+22.90% 8.15TCr
Weighted average by Cap. +0.58%+2.97%-11.98%+20.40%

Financials

2026 *2027 *
Net sales 472.46Cr 2.37TCr 420.54Cr 389.75Cr 353.18Cr 663.75Cr 45TCr 674.86Cr 4.68TCr 1.84TCr 23TCr 1.77TCr 1.74TCr 75TCr 514.51Cr 2.58TCr 457.97Cr 424.44Cr 384.61Cr 722.83Cr 49TCr 734.93Cr 5.09TCr 2TCr 26TCr 1.93TCr 1.89TCr 81TCr
Net income 117.88Cr 591.37Cr 104.92Cr 97Cr 88Cr 165.6Cr 11TCr 168.37Cr 1.17TCr 458.37Cr 5.84TCr 442.15Cr 432.98Cr 19TCr 131.15Cr 657.97Cr 116.74Cr 108.19Cr 98Cr 184.25Cr 12TCr 187.34Cr 1.3TCr 509.99Cr 6.5TCr 491.94Cr 481.74Cr 21TCr
Net Debt 37Cr 184.4Cr 33Cr 30Cr 27Cr 52Cr 3.48TCr 53Cr 363.83Cr 142.93Cr 1.82TCr 137.87Cr 135.01Cr 5.81TCr -9.85Cr -49Cr -8.77Cr -8.12Cr -7.36Cr -14Cr -933.03Cr -14Cr -97Cr -38Cr -488.27Cr -37Cr -36Cr -1.56TCr
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
15/26/15 R$546.43 +2.81% 3
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
555.80USD
Average target price
705.50USD
Spread / Average Target
+26.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IDEXX Laboratories, Inc.